Engineering Nanoplatform for Combined Cancer Therapeutics via Complementary Autophagy Inhibition
Open Access
- 7 January 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (2) , 657
Abstract
Despite advances in the development of tumor treatments, mortality from cancer continues to increase. Nanotechnology is expected to provide an innovative anti-cancer therapy, to combat challenges such as multidrug resistance and tumor recurrence. Nevertheless, tumors can greatly rely on autophagy as an alternative source for metabolites, and which desensitizes cancer cells to therapeutic stress, hindering the success of any current treatment paradigm. Autophagy is a conserved process by which cells turn over their own constituents to maintain cellular homeostasis. The multistep autophagic pathway provides potentially druggable targets to inhibit pro-survival autophagy under various therapeutic stimuli. In this review, we focus on autophagy inhibition based on functional nanoplatforms, which may be a potential strategy to increase therapeutic sensitivity in combinational cancer therapies, including chemotherapy, radiotherapy, phototherapy, sonodynamic therapy, and immunotherapy.Keywords
Funding Information
- National Natural Science Foundation of China (81773185, 81272453, 81472850)
This publication has 67 references indexed in Scilit:
- Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer TherapiesACS Biomaterials Science & Engineering, 2015
- A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagyNature Chemical Biology, 2014
- Hollow silica nanoparticles loaded with hydrophobic phthalocyanine for near-infrared photodynamic and photothermal combination therapyBiomaterials, 2013
- Autophagy in cancer: Having your cake and eating itSeminars in Cancer Biology, 2011
- In VivoDelivery of Silica Nanorattle Encapsulated Docetaxel for Liver Cancer Therapy with Low Toxicity and High EfficacyACS Nano, 2010
- Dual Role of 3-Methyladenine in Modulation of Autophagy via Different Temporal Patterns of Inhibition on Class I and III Phosphoinositide 3-KinaseJournal of Biological Chemistry, 2010
- Chapter 1 Monitoring Autophagy in Mammalian Cultured Cells through the Dynamics of LC32009
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Autophagy: from phenomenology to molecular understanding in less than a decadeNature Reviews Molecular Cell Biology, 2007
- Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphomaJournal of Clinical Investigation, 2007